Clinical study for the effectiveness of Unani drug in eczema
Phase 2
- Conditions
- Health Condition 1: L259- Unspecified contact dermatitis, unspecified cause
- Registration Number
- CTRI/2020/03/023888
- Lead Sponsor
- ational Research Institute Of Unani Medicine For Skin Disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having following symptoms. Erythema,
Scaling,
Lichenification,
Excoriation,
Burning sensation,
Itching.
Exclusion Criteria
Patients aged below 18 years and above 65 years.
Patients on concomitant therapy.
Co morbid paients.
Diabetic paients.
Pregnant and Lactating women.
signifiodicant arpulmonary/cardiovascular/hepato-renal dysfunction.
known cases of Immunocompromised states(HIV/AIDS) Malignancies.
Patients not willing to attend treatment schedule regularly.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EASI(Eczema Area and Severity Index),Timepoint: 1st week,2nd week,3rd week,4th week,5th week,6th week
- Secondary Outcome Measures
Name Time Method CDSQ(Contact Dermatitis Specific QuestionnaireTimepoint: At 1,2,3,4,5,6,weeks